-
Rare Action Network > About > News > FDA Public Meeting
Archives
1-1 of 1 item
NORD Issues Statement in Response to PDUFA VI Commitment Letter
July 21, 2016
On July 15, the Food and Drug Administration released the performance goals letter for the reauthorization of the Prescription Drug User Fee Act, also known as PDUFA VI. The PDUFA program is the agreement between the FDA and the pharmaceutical industry to pay user fees to facilitate the review of pharmaceutical products. PDUFA must be reauthorized […]
1-1 of 1 item
Quick Search
Subscribe
Blog Categories
Archives